Venmax Drugs & Pharmaceuticals
VENMAXBSE

Venmax Drugs & Pharmaceuticals

₹21.18-1.76 (7.67%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
19.26
Today’s high
24.99
52 week low
19.01
52 week high
36.96
Open price
24.99
Previous close
22.94
Live volume
5,361
Lower circuit
16.95
Upper circuit
25.41

Fundamentals

Market Cap
₹27Cr
ROE
1.76%
P/E Ratio(TTM)
109.24
EPS(TTM)
0.21
P/B Ratio
1.88
Dividend Yield
0.00%
Industry P/E
44.85
Book Value
12.18
Debt to Equity
0.02
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹4.03
+148.77%
Profit (Cr)
₹0.11
+266.67%
01.534.56
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+199%
3Y CAGR-2%
Profit growthValue
1Y (TTM)-86%

About

Venmax is primarily engaged in the manufacturing and trading of pharmaceutical formulations, drug intermediates, and Active Pharmaceutical Ingredients (APIs). The company is currently developing oncology products and is in the planning stages of establishing a new manufacturing unit with a cGMP facility at the Hyderabad Pharma Cluster to target export markets.;
CEO/MD
Mr. Venkata Rao Sadhanala
Founded in
1988
BSE symbol
531015

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
86.20%
Promoters
13.80%
2026
14
May
Quarterly & Annual Result
Release date
7
Feb
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
23
Jul
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks